FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Philippe Beutels

Research Profile

Activities & Behaviors

Cost Benefit Analysis

Geographic Areas

Procedures

Living Beings

Infants

Concepts & Ideas

Chemicals & Drugs

Disorders

Phenomena

Disease Outbreaks

Co-author Network

Publications

TOP 3
Jessica Fraeyman; Brian Godman; Guido Van Hal; Philippe Beutels
The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Jeroen Luyten; Veronica Dorgali; Niel Hens; Philippe Beutels
Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study.
J Bilcke; K Callaert; M Callens; F de Smet; C Marais; B Ogunjimi; J Ramet; Pierre Van Damme; E van Kerschaver; Philippe Beutels
The health and economic burden of chickenpox and herpes zoster in Belgium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Philippe Beutels (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jessica Fraeyman; Brian Godman; Guido Van Hal; Philippe Beutels
The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium.
Expert review of pharmacoeconomics & outcomes research 2013;13(1):141-51.
2013: Jeroen Luyten; Veronica Dorgali; Niel Hens; Philippe Beutels
Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study.
Social science & medicine (1982) 2013;77():84-9.
2012: J Bilcke; K Callaert; M Callens; F de Smet; C Marais; B Ogunjimi; J Ramet; Pierre Van Damme; E van Kerschaver; Philippe Beutels
The health and economic burden of chickenpox and herpes zoster in Belgium.
Epidemiology and infection 2012;140(11):2096-109.
2012: Jeroen Luyten; Pierre Van Damme; Stefaan Van de Sande; Koen De Schrijver; Philippe Beutels
Cost-effectiveness of hepatitis A vaccination for adults in Belgium.
Vaccine 2012;30(42):6070-80.
2012: Anthony T Newall; Mark Jit; Philippe Beutels
Economic evaluations of childhood influenza vaccination: a critical review.
PharmacoEconomics 2012;30(8):647-60.
2012: Nele Goeyvaerts; Niel Hens; Heidi Theeten; Pierre Van Damme; Marc Aerts; Philippe Beutels
Estimating vaccination coverage for the trivalent measles-mumps-rubella vaccine from trivariate serological data.
Statistics in medicine 2012;31(14):1432-49.
2012: J Fraeyman; Roy Remmen; Guido Van Hal; Hans De Loof; G R Y De Meyer; Philippe Beutels
Potential impact of policy regulation and generic competition on sales of cholesterol lowering medication, antidepressants and acid blocking agents in Belgium.
Acta clinica Belgica 2012;67(3):160-71.
2012: Joke Bilcke; Niel Hens; Frank Hulstaert; Benson Ogunjimi; Pierre Van Damme; Philippe Beutels
Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?
Vaccine 2012;30(17):2795-800.
2012: Benson Ogunjimi; Pierre Van Damme; V F I Van Tendeloo; Philippe Beutels
What counts in cytometric analysis to document vaccine immunogenicity?
Human vaccines & immunotherapeutics 2012;8(4):499-500.
2012: Lander Willem; Dennis L Chao; Niel Hens; Kim Van Kerckhove; Philippe Beutels
A nice day for an infection? Weather conditions and social contact patterns relevant to influenza transmission.
PloS one 2012;7(11):e48695.
2012: Mathieu Andraud; Niel Hens; Christiaan Marais; Philippe Beutels
Dynamic epidemiological models for dengue transmission: a systematic review of structural approaches.
PloS one 2012;7(11):e49085.
2012: Benson Ogunjimi; Dieter Peeters; Philippe Beutels; Niel Hens; Ronald Malfait; Pierre Van Damme; V F I Van Tendeloo; Evelien Smits
Sampling site matters when counting lymphocyte subpopulations.
PloS one 2012;7(7):e41405.
2012: Mathieu Andraud; Philippe Beutels; Olivier Lejeune; Jammbe Z Musoro; Benson Ogunjimi; Niel Hens
Living on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.
PLoS computational biology 2012;8(3):e1002418.
2011: Girma Minalu; Geert Molenberghs; Arno Muller; Ann Versporten; Niels Adriaenssens; Marc Aerts; Philippe Beutels; Samuel Coenen; Herman Goossens; Niel Hens
Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis.
The Journal of antimicrobial chemotherapy 2011;66 Suppl 6():vi79-87.
2011: Eva Lefevere; Heidi Theeten; Philippe Beutels; Frank De Smet; Niel Hens; Karel Van den Bosch; Pierre Van Damme
Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium).
Vaccine 2011;29(46):8390-6.
2011: Benson Ogunjimi; Evelien Smits; Niel Hens; Annick Hens; Kevin Lenders; Margareta Ieven; V F I Van Tendeloo; Pierre Van Damme; Philippe Beutels
Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents.
Viral immunology 2011;24(2):151-7.
2011: Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.
Biostatistics (Oxford, England) 2011;12(2):283-302.
2011: Heidi Theeten; V Hutse; N Hens; Y Yavuz; Karel Hoppenbrouwers; Philippe Beutels; Robert Vranckx; Pierre Van Damme
Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Epidemiology and infection 2011;139(4):494-504.
2011: Mark E Beatty; Philippe Beutels; Martin I Meltzer; Donald S Shepard; Joachim Hombach; Raymond Hutubessy; Damien Dessis; Laurent Coudeville; Benoit Dervaux; Ole Wichmann; Harold S Margolis; Joel N Kuritsky
Health economics of dengue: a systematic literature review and expert panel's assessment.
The American journal of tropical medicine and hygiene 2011;84(3):473-88.
2011: Jeroen Luyten; Christiaan Marais; Niel Hens; Koen De Schrijver; Philippe Beutels
Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2011;14(2):282-90.
2011: Niel Hens; Marc Van Ranst; Marc Aerts; Emmanuel Robesyn; Pierre Van Damme; Philippe Beutels
Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009.
Vaccine 2011;29(5):896-904.
2011: Nathorn Chaiyakunapruk; John W Edmunds; Ana Maria Henao; Joachim Hombach; Raymond Hutubessy; Alessia Melegaro; Ratchadaporn Somkrua; Philippe Beutels
Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools.
BMC medicine 2011;9():53.
2010: Marcus Richard Keogh-Brown; Richard D Smith; John W Edmunds; Philippe Beutels
The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands.
The European journal of health economics : HEPAC : health economics in prevention and care 2010;11(6):543-54.
2010: Mark Jit; Marie-Josée J Mangen; Hugues Melliez; Yazdan Yazdanpanah; Joke Bilcke; Heini Salo; W John Edmunds; Philippe Beutels
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe".
Vaccine 2010;28(47):7457-9.
2010: Marcus R Keogh-Brown; Simon Wren-Lewis; W John Edmunds; Philippe Beutels; Richard D Smith
The possible macroeconomic impact on the UK of an influenza pandemic.
Health economics 2010;19(11):1345-60.
2010: Philippe Beutels; Mark Jit
A brief history of economic evaluation for human papillomavirus vaccination policy.
Sexual health 2010;7(3):352-8.
2010: N Hens; Marc Aerts; Christel Faes; Ziv Shkedy; O Lejeune; Pierre Van Damme; Philippe Beutels
Seventy-five years of estimating the force of infection from current status data.
Epidemiology and infection 2010;138(6):802-12.
2010: Kevin Lenders; Benson Ogunjimi; Philippe Beutels; Niel Hens; Pierre Van Damme; Zwi N Berneman; V F I Van Tendeloo; Evelien L J M Smits
The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT.
Journal of immunological methods 2010;357(1-2):51-4.
2010: DAMIAN WALKER; Raymond Hutubessy; Philippe Beutels
WHO Guide for standardisation of economic evaluations of immunization programmes.
Vaccine 2010;28(11):2356-9.
2009: Jelle Matthijnssens; Joke Bilcke; Max Ciarlet; Vito Martella; Krisztián Bányai; Mustafizur Rahman; Mark Zeller; Philippe Beutels; Pierre Van Damme; Marc Van Ranst
Rotavirus disease and vaccination: impact on genotype diversity.
Future microbiology 2009;4(10):1303-16.
2009: Philippe Beutels; Na Jia; Qing-Yi Zhou; Richard Smith; Wu-chun Cao; Sake J de Vlas
The economic impact of SARS in Beijing, China.
Tropical medicine & international health : TM & IH 2009;14 Suppl 1():85-91.
2009: Mark Jit; Joke Bilcke; Marie-Josée J Mangen; Heini Salo; Hugues Melliez; W John Edmunds; Yazdanpanah Yazdan; Philippe Beutels
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe.
Vaccine 2009;27(44):6121-8.
2009: Benson Ogunjimi; Niel Hens; Nele Goeyvaerts; Marc Aerts; Pierre Van Damme; Philippe Beutels
Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella.
Mathematical biosciences 2009;218(2):80-7.
2009: Heidi Theeten; Niel Hens; Marc Aerts; Corinne Vandermeulen; Mathieu Roelants; Karel Hoppenbrouwers; Pierre Van Damme; Philippe Beutels
Common attitudes about concomitant vaccine injections for infants and adolescents in Flanders, Belgium.
Vaccine 2009;27(13):1964-9.
2009: Niel Hens; Girma Minalu Ayele; Nele Goeyvaerts; Marc Aerts; Joel Mossong; John W Edmunds; Philippe Beutels
Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries.
BMC infectious diseases 2009;9():187.
2009: C Simoens; M Sabbe; P Van Damme; Philippe Beutels; Marc Arbyn
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008.
Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2009;14(46):.
2009: Jeroen Luyten; Philippe Beutels
Costing infectious disease outbreaks for economic evaluation: a review for hepatitis A.
PharmacoEconomics 2009;27(5):379-89.
2009: Joke Bilcke; Pierre Van Damme; Marc Van Ranst; Niel Hens; Marc Aerts; Philippe Beutels
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis.
PloS one 2009;4(6):e6060.
2009: Joke Bilcke; Philippe Beutels
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources.
PharmacoEconomics 2009;27(4):281-97.
2009: Niel Hens; Nele Goeyvaerts; Marc Aerts; Ziv Shkedy; Pierre Van Damme; Philippe Beutels
Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium.
BMC infectious diseases 2009;9():5.
2009: Marc Arbyn; Ina Benoy; Cindy Simoens; Johannes Bogers; Philippe Beutels; Christophe Depuydt
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):321-30.
2009: Heidi Theeten; Niel Hens; Marc Aerts; Corinne Vandermeulen; Mathieu Roelants; Karel Hoppenbrouwers; Pierre Van Damme; Philippe Beutels
Caregivers' willingness to pay to reduce the number of vaccine injections in infants.
The Pediatric infectious disease journal 2009;28(1):61-3.
2009: Joke Bilcke; Pierre Van Damme; Philippe Beutels
Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
Medical decision making : an international journal of the Society for Medical Decision Making 2009;29(1):33-50.
2008: Joke Bilcke; Pierre Van Damme; Frank De Smet; Germaine Hanquet; Marc Van Ranst; Philippe Beutels
The health and economic burden of rotavirus disease in Belgium.
European journal of pediatrics 2008;167(12):1409-19.
2008: Philippe Beutels; Paul A Scuffham; C Raina MacIntyre
Funding of drugs: do vaccines warrant a different approach?
The Lancet infectious diseases 2008;8(11):727-33.
2008: Philippe Beutels; W J Edmunds; R D Smith
Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern.
Health economics 2008;17(11):1317-22.
2008: N Hens; M Aerts; Z Shkedy; H Theeten; P Van Damme; Philippe Beutels
Modelling multisera data: the estimation of new joint and conditional epidemiological parameters.
Statistics in medicine 2008;27(14):2651-64.
2008: Joël Mossong; Niel Hens; Mark Jit; Philippe Beutels; Kari Auranen; Rafael Mikolajczyk; Marco Massari; Stefania Salmaso; Gianpaolo Scalia Tomba; Jacco Wallinga; Janneke Heijne; Malgorzata Sadkowska-Todys; Magdalena Rosinska; W John Edmunds
Social contacts and mixing patterns relevant to the spread of infectious diseases.
PLoS medicine 2008;5(3):e74.
2008: N Hens; Marc Aerts; Ziv Shkedy; P Kung'u Kimani; M Kojouhorova; Pierre Van Damme; Philippe Beutels
Estimating the impact of vaccination using age-time-dependent incidence rates of hepatitis B.
Epidemiology and infection 2008;136(3):341-51.
2007: Anthony T Newall; Philippe Beutels; Kristine Macartney; James Wood; C Raina MacIntyre
The cost-effectiveness of rotavirus vaccination in Australia.
Vaccine 2007;25(52):8851-60.
2007: M Zia Sadique; W John Edmunds; Richard D Smith; William Jan Meerding; Onno de Zwart; Johannes Brug; Philippe Beutels
Precautionary behavior in response to perceived threat of pandemic influenza.
Emerging infectious diseases 2007;13(9):1307-13.
2007: Anthony T Newall; Philippe Beutels; James G Wood; W John Edmunds; C Raina MacIntyre
Cost-effectiveness analyses of human papillomavirus vaccination.
The Lancet infectious diseases 2007;7(4):289-96.
2007: Froukje Oosterhuis-Kafeja; Philippe Beutels; Pierre Van Damme
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).
Vaccine 2007;25(12):2194-212.
2007: Philippe Beutels; Pierre Van Damme
Effectiveness of seven-valent pneumococcal conjugate vaccine.
Lancet 2007;369(9560):460; author reply 460.
2007: Philippe Beutels; Nancy Thiry; Pierre Van Damme
Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).
Vaccine 2007;25(8):1355-67.
2006: Philippe Beutels; Ziv Shkedy; Marc Aerts; Pierre Van Damme
Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface.
Epidemiology and infection 2006;134(6):1158-66.
2006: Ziv Shkedy; Marc Aerts; Geert Molenberghs; Philippe Beutels; Pierre Van Damme
Modelling age-dependent force of infection from prevalence data using fractional polynomials.
Statistics in medicine 2006;25(9):1577-91.
2005: Nancy Thiry; Philippe Beutels; Pierre Van Damme
Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results.
Acta clinica Belgica 2005;60(6):338-44.
2005: Kristine Macartney; Philippe Beutels; Peter McIntyre; Margaret A Burgess
Varicella vaccination in Australia.
Journal of paediatrics and child health 2005;41(11):544-52.
2005: F Reignier; Luisa Romano'; Nancy Thiry; Philippe Beutels; Pierre Van Damme; C Fau; C Gaspard; Valérie Mamoux; A Zanetti; Daniel Floret
[Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)].
Médecine et maladies infectieuses 2005;35(4):192-6.
2005: Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.
PharmacoEconomics 2005;23(9):855-74.
2004: Philippe Beutels; Rosalie C Viney
Comments on the Prosser et Al approach to value disease reduction in children.
Pediatrics 2004;114(5):1375; author reply 1375-6.
2004: Nancy Thiry; Philippe Beutels; Francesco Tancredi; Luisa Romano'; Alessandro Zanetti; Paolo Bonanni; Giovanni Gabutti; Pierre Van Damme
An economic evaluation of varicella vaccination in Italian adolescents.
Vaccine 2004;22(27-28):3546-62.
2004: Philippe Beutels
Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination.
Vaccine 2004;22(25-26):3312-22.
2004: Maarten J Postma; Jasper M Bos; Philippe Beutels; H Schilthuis; J A R van den Hoek
Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
Vaccine 2004;22(15-16):1862-7.
2004: Maarten J Postma; Jasper M Bos; Robert Welte; Ronald de Groot; W Luytjes; Hans Rümke; Philippe Beutels
Do costs of varicella justify routine infant vaccination? Pharmacoeconomic and clinical considerations.
The European journal of health economics : HEPAC : health economics in prevention and care 2004;5(1):54-7.
2004: Jasper M Bos; Philippe Beutels; Lieven Annemans; Maarten J Postma
Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases.
PharmacoEconomics 2004;22(18):1171-9.
2004: Diana De Graeve; Philippe Beutels
Economic aspects of pneumococcal pneumonia: a review of the literature.
PharmacoEconomics 2004;22(11):719-40.
2003: Philippe Beutels; Eddy Van Doorslaer; Pierre Van Damme; Jane Hall
Methodological issues and new developments in the economic evaluation of vaccines.
Expert review of vaccines 2003;2(5):649-60.
2003: Hélène Carabin; W John Edmunds; M Gyldmark; Philippe Beutels; Daniel Lévy-Bruhl; H Salo; U K Griffiths
The cost of measles in industrialised countries.
Vaccine 2003;21(27-30):4167-77.
2003: Maarten J Postma; Marie-Louise A Heijnen; Philippe Beutels; Johannes C Jager
Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
Expert review of vaccines 2003;2(4):477-82.
2003: Maarten J Postma; M A Heijnen; R de Vries; Philippe Beutels; Johannes C Jager
[Splenectomy and pneumococcal vaccination].
Nederlands tijdschrift voor geneeskunde 2003;147(23):1141-2; author reply 1142.
2003: Philippe Beutels; N J Gay
Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country.
Epidemiology and infection 2003;130(2):273-83.
2003: Philippe Beutels; Ziv Shkedy; Sergey Mukomolov; Marc Aerts; E Shargorodskaya; V Plotnikova; Geert Molenberghs; Pierre Van Damme
Hepatitis B in St Petersburg, Russia (1994-1999): incidence, prevalence and force of infection.
Journal of viral hepatitis 2003;10(2):141-9.
2003: Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Economic evaluations of varicella vaccination programmes: a review of the literature.
PharmacoEconomics 2003;21(1):13-38.
2002: Nancy Thiry; Philippe Beutels; Ziv Shkedy; Robert Vranckx; Corinne Vandermeulen; Marie Van Der Wielen; Pierre Van Damme
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium).
European journal of pediatrics 2002;161(11):588-93.
2002: Philippe Beutels; Pierre Van Damme; Viviane Van Casteren; N J Gay; Koen De Schrijver; André Meheus
The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).
Vaccine 2002;20(29-30):3551-9.
2002: Maarten J Postma; Marie-Louise A Heijnen; Philippe Beutels; Johannes C Jager
[Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis].
Nederlands tijdschrift voor geneeskunde 2002;146(18):855-9.
2002: Philippe Beutels; W John Edmunds; Fernando Antoñanzas; ardine de wit; David Evans; Rachel Feilden; A Mark Fendrick; Gary M Ginsberg; Henry A Glick; Eric Mast; Marc Péchevis; Eddy Van Doorslaer; Ben A van Hout
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
PharmacoEconomics 2002;20(1):1-7.
2001: Philippe Beutels
Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).
Health economics 2001;10(8):751-74.
2001: Philippe Beutels; M J Postma
Economic evaluations of adult pneumococcal vaccination strategies.
Expert review of pharmacoeconomics & outcomes research 2001;1(1):47-58.
2001: Ludo Mahieu; N Buitenweg; Philippe Beutels; Jozef De Dooy
Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit.
The Journal of hospital infection 2001;47(3):223-9.
2000: Philippe Beutels; E I Musabaev; P Van Damme; T Yasin
The disease burden of hepatitis B in Uzbekistan.
The Journal of infection 2000;40(3):234-41.
2000: Koen Van Herck; Philippe Beutels; Pierre Van Damme; M Beutels; J Van den Dries; P Briantais; E Vidor
Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
Journal of medical virology 2000;60(1):1-7.
1999: Philippe Beutels; Pierre Van Damme
Hepatitis A vaccine for secondary hepatitis A infection.
Lancet 1999;354(9175):340-1; author reply 342-3.
1999: Philippe Beutels; Paolo Bonanni; G Tormans; F Canale; Pietro Crovari
An economic evaluation of universal pertussis vaccination in Italy.
Vaccine 1999;17(19):2400-9.
1998: Philippe Beutels
Economic evaluations applied to HB vaccination: general observations.
Vaccine 1998;16 Suppl():S84-92.
1998: A H Buma; Philippe Beutels; P van Damme; G Tormans; Eddy Van Doorslaer; A Leentvaar-Kuijpers
An economic evaluation of hepatitis A vaccination in Dutch military personnel.
Military medicine 1998;163(8):564-7.
1998: Philippe Beutels
[Economic evaluations of pneumococcal vaccination. A critical analysis].
Presse médicale (Paris, France : 1983) 1998;27 Suppl 1():33-8.
1996: Philippe Beutels; R Clara; G Tormans; Eddy Van Doorslaer; Pierre Van Damme
Costs and benefits of routine varicella vaccination in German children.
The Journal of infectious diseases 1996;174 Suppl 3():S335-41.
1996: T Gutersohn; Robert Steffen; Pierre Van Damme; F Holdener; Philippe Beutels
Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination.
Aviation, space, and environmental medicine 1996;67(2):153-6.
1996: Pierre Van Damme; Philippe Beutels
Economic evaluation of vaccination.
PharmacoEconomics 1996;9 Suppl 3():8-15; discussion 23-5.
1995: Eddy Van Doorslaer; G Tormans; Pierre Van Damme; Philippe Beutels
Cost effectiveness of alternative hepatitis A immunisation strategies.
PharmacoEconomics 1995;8(1):5-8.
1995: Pierre Van Damme; Eddy Van Doorslaer; G Tormans; Philippe Beutels
Travel prophylaxis. Assumptions were confusing.
BMJ (Clinical research ed.) 1995;310(6976):402.
1995: Pierre Van Damme; G Tormans; Philippe Beutels; Eddy Van Doorslaer
Hepatitis B prevention in Europe: a preliminary economic evaluation.
Vaccine 1995;13 Suppl 1():S54-7.